295 related articles for article (PubMed ID: 25228336)
21. Outcome of Gleason 3 + 5 = 8 Prostate Cancer Diagnosed on Needle Biopsy: Prognostic Comparison with Gleason 4 + 4 = 8.
Harding-Jackson N; Kryvenko ON; Whittington EE; Eastwood DC; Tjionas GA; Jorda M; Iczkowski KA
J Urol; 2016 Oct; 196(4):1076-81. PubMed ID: 27265220
[TBL] [Abstract][Full Text] [Related]
22. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.
Hattab EM; Koch MO; Eble JN; Lin H; Cheng L
J Urol; 2006 May; 175(5):1695-9; discussion 1699. PubMed ID: 16600733
[TBL] [Abstract][Full Text] [Related]
23. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
Oh JJ; Hong SK; Lee JK; Lee BK; Lee S; Kwon OS; Byun SS; Lee SE
BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236
[TBL] [Abstract][Full Text] [Related]
24. Tertiary Gleason pattern 5 on needle biopsy predicts greater tumour volume on radical prostatectomy.
Ranaweera M; Samaratunga H; Duffy D; Klopfer K; Brunelli M; Martignoni G; Delahunt B
Pathology; 2011 Dec; 43(7):693-6. PubMed ID: 22002115
[TBL] [Abstract][Full Text] [Related]
25. Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostate.
Gonzalgo ML; Bastian PJ; Mangold LA; Trock BJ; Epstein JI; Walsh PC; Partin AW
Urology; 2006 Jan; 67(1):115-9. PubMed ID: 16413345
[TBL] [Abstract][Full Text] [Related]
26. Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors.
Grober ED; Tsihlias J; Jewett MA; Sweet JM; Evans AJ; Trachtenberg J; Robinette M; Nam RK
Can J Urol; 2004 Feb; 11(1):2157-62. PubMed ID: 15003158
[TBL] [Abstract][Full Text] [Related]
27. Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment.
García-Cruz E; Piqueras M; Huguet J; Peri L; Izquierdo L; Musquera M; Franco A; Alvarez-Vijande R; Ribal MJ; Alcaraz A
BJU Int; 2012 Dec; 110(11 Pt B):E541-6. PubMed ID: 22584031
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis in radical prostatectomies with high-grade prostate cancer is associated with multiple poor prognostic features and a high prevalence of residual disease.
Acosta AM; Al Rasheed MRH; Rauscher GH; Vormittag E; Mon KS; Sharif A; Kajdacsy-Balla A; Mohapatra G
Hum Pathol; 2018 May; 75():1-9. PubMed ID: 29180249
[TBL] [Abstract][Full Text] [Related]
29. Gleason grade 5 prostate cancer: sub-patterns and prognosis.
Atallah C; Toi A; van der Kwast TH
Pathology; 2021 Jan; 53(1):3-11. PubMed ID: 33143905
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical expression of Ets-related gene-transcriptional factor in adenocarcinoma prostate and its correlation with Gleason score.
Mannan R; Bhasin TS; Manjari M; Singh G; Bhatia PK; Sharma S
Indian J Pathol Microbiol; 2016; 59(4):489-495. PubMed ID: 27721279
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis of "Poorly Formed Glands" Gleason Pattern 4 Prostatic Adenocarcinoma on Needle Biopsy: An Interobserver Reproducibility Study Among Urologic Pathologists With Recommendations.
Zhou M; Li J; Cheng L; Egevad L; Deng FM; Kunju LP; Magi-Galluzzi C; Melamed J; Mehra R; Mendrinos S; Osunkoya AO; Paner G; Shen SS; Tsuzuki T; Trpkov K; Tian W; Yang X; Shah RB
Am J Surg Pathol; 2015 Oct; 39(10):1331-9. PubMed ID: 26099009
[TBL] [Abstract][Full Text] [Related]
32. Gleason grading: past, present and future.
Delahunt B; Miller RJ; Srigley JR; Evans AJ; Samaratunga H
Histopathology; 2012 Jan; 60(1):75-86. PubMed ID: 22212079
[TBL] [Abstract][Full Text] [Related]
33. Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival.
Turker P; Bas E; Bozkurt S; Günlüsoy B; Sezgin A; Postacı H; Turkeri L
Urol Oncol; 2013 Jan; 31(1):93-8. PubMed ID: 21316989
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo model.
Tollefson MK; Karnes RJ; Kwon ED; Lohse CM; Rangel LJ; Mynderse LA; Cheville JC; Sebo TJ
Mayo Clin Proc; 2014 Mar; 89(3):308-18. PubMed ID: 24486077
[TBL] [Abstract][Full Text] [Related]
35. Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation.
Sabolch A; Feng FY; Daignault-Newton S; Halverson S; Blas K; Phelps L; Olson KB; Sandler HM; Hamstra DA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e351-60. PubMed ID: 21493015
[TBL] [Abstract][Full Text] [Related]
36. Gleason score 7 adenocarcinoma of the prostate with lymph node metastases: analysis of 184 radical prostatectomy specimens.
Kryvenko ON; Gupta NS; Virani N; Schultz D; Gomez J; Amin A; Lane Z; Epstein JI
Arch Pathol Lab Med; 2013 May; 137(5):610-7. PubMed ID: 23627451
[TBL] [Abstract][Full Text] [Related]
37. Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?
Makarov DV; Sanderson H; Partin AW; Epstein JI
J Urol; 2002 Jun; 167(6):2440-2. PubMed ID: 11992053
[TBL] [Abstract][Full Text] [Related]
38. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
[TBL] [Abstract][Full Text] [Related]
39. Implications of the International Society of Urological Pathology modified Gleason grading system.
Egevad L; Mazzucchelli R; Montironi R
Arch Pathol Lab Med; 2012 Apr; 136(4):426-34. PubMed ID: 22458905
[TBL] [Abstract][Full Text] [Related]
40. Can single positive core prostate cancer at biopsy be considered a low-risk disease after radical prostatectomy?
Ricardo Kupka da S; Dall'Oglio MF; Sant'Ana AC; Pontes J; Srougi M
Int Braz J Urol; 2013; 39(6):800-7. PubMed ID: 24456772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
